Concepedia
4
Publications
187
Citations
H-Index
2021
Active since
Affiliations
Cognition Therapeutics (United States)(Current)
Kelsie M. LaBarbera is an author at Cognition Therapeutics (United States).
Publications per year
2021–2021
Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification
Nicholas J. Izzo, Carla M. Yuede, Kelsie M. LaBarbera et al. · Alzheimer s & Dementia · 2021 · 97 citations · Full text
Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synuclein
Colleen S. Limegrover, Raymond Yurko, Nicholas J. Izzo et al. · Journal of Neuroscience Research · 2021 · 40 citations · Full text
Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer’s Disease
Gilbert M. Rishton, Gary C. Look, Zhi‐Jie Ni et al. · ACS Medicinal Chemistry Letters · 2021 · 40 citations · Full text
Modeling the mature CNS: A predictive screening platform for neurodegenerative disease drug discovery
Kelsie M. LaBarbera, Colleen S. Limegrover, Courtney Rehak et al. · Journal of Neuroscience Methods · 2021 · 10 citations · Full text
Rows per page
1–4 of 4